Healthcare & Life Sciences
InterVenn Biosciences
United Statesintervenn.com/
InterVenn is a series b startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2017
Founded
3
Investors
About InterVenn Biosciences
InterVenn Biosciences is a company founded in 2017 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
InterVenn Biosciences develops an AI-driven glycoproteomics platform to identify glycoprotein biomarkers for disease detection, progression monitoring, and therapeutic response. The company provides biomarker discovery and diagnostic/monitoring solutions to clinical and research partners.
Explore InterVenn Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.